MindBio Therapeutics Corp, a biotechnology company commercialising AI-driven voice technology for drug and alcohol intoxication detection, is pleased to announce that the Company has filed patent applications for its technology that uses voice and AI to detect intoxication.

The technology developed by MindBio is a game changer for intoxication detection, particularly where drug and alcohol testing is mandated by regulators, such as the mining, aviation and construction industries and in law enforcement, where high-volume testing at scale for a variety of drugs and alcohol presents major challenges, is time-consuming, physically invasive and expensive.  

In a world first, MindBio has developed an AI model that powers its Edge AI Intoxication Detection Kiosks, using over 50 million data points to predict drug and alcohol intoxication with remarkable reliability and accuracy, just by using the human voice. The Company’s novel discoveries that have led to its patent application filings allow it to use its prediction technology to detect a range of substances that affect the central nervous system and human cognition and performance.  

The Company also announced that it is on track for the delivery of its hardware and software solution, an Edge AI touchscreen kiosk for commercial testing, specifically for the mining and aviation industries, by the end of Q2, 2026.

The Company’s CEO, Justin Hanka said, “The digital health diagnostics market represents a significant opportunity for MindBio to leverage its Voice AI diagnostics technology with a first mover commercialisation advantage in drug and alcohol intoxication detection.”